PPIA and non-small cell lung carcinoma: Peptidyl-prolyl isomerase A/cyclophilin A (PPIA/CYPA) has been reported as overexpressed in BC, promoting cell survival [17], cancer cell growth, malignant transformation, metastasis, drug resistance [38], anti-apoptosis [39], and EMT in NSCLC cells via p38 MAPK [40].